Immune Checkpoint Inhibitor-Induced Myocarditis With Concurrent Myasthenia Gravis

Can J Cardiol. 2023 Nov;39(11):1646-1648. doi: 10.1016/j.cjca.2023.06.007. Epub 2023 Jun 15.

Authors

Jason Kuniyoshi¹, Ricky Huang¹, Horyun Choi¹, Monika Bernas¹, Witina Techasatian¹, Yoshito Nishimura²

Affiliations

¹ Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii, USA.
² Department of Medicine, John A. Burns School of Medicine, University of Hawai'i, Honolulu, Hawaii, USA. Electronic address: yoshiton@hawaii.edu.

PMID: 37330137
DOI: 10.1016/j.cjca.2023.06.007

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Agents, Immunological* / adverse effects
Humans
Immune Checkpoint Inhibitors / adverse effects
Myasthenia Gravis* / chemically induced
Myasthenia Gravis* / complications
Myasthenia Gravis* / diagnosis
Myocarditis* / chemically induced
Myocarditis* / diagnosis
Myocarditis* / drug therapy

Substances

Immune Checkpoint Inhibitors
Antineoplastic Agents, Immunological